Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Gianpaolo Ussia"'
Autor:
Ciro Mastroianni, Francesco Nappi, Gianpaolo Ussia, Valeria Cammalleri, Massimo Chello, Mario Lusini
Bicuspid aortic valve (BAV) disease is the most common congenital abnormality and is characterized by a risk of premature aortic valve disease, predominantly aortic stenosis. Surgery remains the treatment of choice for patients with symptomatic BAV d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e136d4f483b2c6dee9caa48206151f3b
http://hdl.handle.net/2108/305000
http://hdl.handle.net/2108/305000
Autor:
Sonia Petronio, Antonio L. Bartorelli, Carmen Spaccarotella, Giuseppe Tarantini, Roberto Violini, Corrado Vassanelli, Paolo Golino, Sergio Berti, Giovanni Esposito, Ciro Indolfi, Giuseppe Musumeci, Gianpaolo Ussia, Francesco Romeo, Giuseppe Mercuro, Corrado Tamburino
The introduction of percutaneous treatment of severe aortic stenosis with transcatheter aortic valve implantation (TAVI) remains one of the greatest achievements of interventional cardiology. In fact, TAVI emerged as a better option than either medic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b67eec49a5b4ae780b8ac8525977e4e
http://hdl.handle.net/11588/722667
http://hdl.handle.net/11588/722667
Publikováno v:
Catheterization and Cardiovascular Interventions. 79:777-782
Transcatheter Aortic Valve Implantation with the Core Valve self expanding prosthesis can be complicated by hemodynamic instability in cases of low deployment (implant failure). The management of a low implant may necessitate repositioning the prosth
Autor:
Giovanni Millan, Anna Marchese, Antonino Indelicato, Alessandra Sanfilippo, Wanda Deste, Glauco Cincotta, Corrado Tamburino, Patrizia Aruta, Gianpaolo Ussia, Sarah Mangiafico
Publikováno v:
Journal of Cardiovascular Echography. 21:20-26
Riassunto Obiettivi La sostituzione aortica percutanea (Transcatheter Aortic Valve Implantation, TAVI) rappresenta una tecnica emergente nei pazienti sintomatici con stenosi aortica severa e controindicazione chirurgica. Obiettivo del lavoro e analiz
Autor:
Sebastiano Immè, Marta Chiarandà, Stefano Cannata, Salvatore Scandura, Davide Capodanno, Anna Caggegi, Marco Barbanti, Fabio Dipasqua, Corrado Tamburino, Anna Maria Pistritto, Sandra Giaquinta, Carmelo Grasso, Gianpaolo Ussia, Michele Occhipinti, Sarah Mangiafico, Margherita Ministeri
The aim of this study was to report on the 30-day and 1-year outcomes of percutaneous mitral valve repair with the MitraClip technique in patients with grade ≥3+ mitral regurgitation (MR) at high risk for conventional surgical therapy enrolled in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1755bc77f73c8c9a8a6aa1f12cd5cee
http://hdl.handle.net/20.500.11769/56075
http://hdl.handle.net/20.500.11769/56075
Autor:
Gianpaolo Ussia, Nazzareno Galiè, Riccardo Parlangeli, Angelo Branzi, Paola Passarelli, Bruno Magnani
Publikováno v:
The American Journal of Cardiology. 75:55A-62A
Primary pulmonary hypertension (PPH) is a rare disease of unknown etiology characterized by a constant progression toward right ventricular failure and death. Vasoconstriction is 1 of the pathophysiologic factors responsible for the increase of pulmo
Autor:
Corrado, Tamburino, Davide, Capodanno, Massimiliano, Mulè, Marilena, Scarabelli, Valeria, Cammalleri, Marco, Barbanti, Antonio, Calafiore, Gianpaolo, Ussia
Publikováno v:
The Journal of invasive cardiology. 21(3)
Percutaneous aortic valve replacement (PAVR) is an emerging alternative for high-risk patients with severe aortic stenosis. The aim of this study was to report acute and short-term outcomes of PAVR with the 18 Fr CoreValve Revalving System.From Janua
Autor:
Damiana Fiscella, Davide Capodanno, Piera Capranzano, Francesca Mirabella, George Dangas, Rosario Parisi, Francesco Scardaci, Roxana Mehran, Maria Elena Di Salvo, Gianpaolo Ussia, Alfredo R. Galassi, Corrado Tamburino
Publikováno v:
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions. 73(2)
Objectives: We sought to evaluate the safety and performance of the Janus Tacrolimus-Eluting stent (TES) in an unselected population of patients, without application of restrictive clinical or angiographic criteria. Background: Continued attention to
Autor:
Davide Capodanno, Alessandra Sanfilippo, Corrado Tamburino, Alfredo R. Galassi, Piera Capranzano, Gianpaolo Ussia, Rita Bucalo, Anna Caggegi, Cettina Ruperto
Publikováno v:
Clinical research in cardiology : official journal of the German Cardiac Society. 98(4)
Recent studies of drug-eluting stents (DES) use in routine clinical practice have led to concern regarding their long-term safety and to questions about the adequacy of current antiplatelet therapy guidelines. This study sought to derivate a risk sco
Autor:
Francesco Tagliareni, Corrado Tamburino, Piera Capranzano, Aldo Patti, Grassi R, Antonio Fiscella, Salvatore Tolaro, Nicosia A, Alfredo R. Galassi, Giovanni Saccone, Amerigo Stabile, Rossella Barbagallo, Gianpaolo Ussia, Saverio Ciriminna
Publikováno v:
Journal of cardiovascular medicine (Hagerstown, Md.). 9(2)
OBJECTIVE: This is a multicentre, open label, prospective non-randomized registry, with 9-month angiographic follow-up, conducted to evaluate the safety and effectiveness of drug-eluting stents (DES) when used in high restenosis risk patients from th